HBRIY vs PTCT
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
HBRIY · HARBOUR ENERGY PLC SPON ADR EACH REPR 1 ORD (PST REV SPLT)$3.58 ▼ 2.19%
PTCT · PTC Therapeutics$65.44 ▼ 0.35%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- HBRIY +16.8%
- PTCT -9.7%
Head to head
| Metric | HBRIY | PTCT |
|---|---|---|
| Price | $3.58 | $65.44 |
| Change today | ▼ 2.19% | ▼ 0.35% |
| Market cap | $5.47B | $5.47B |
| Return, 3 months | +6.2% | -12.3% |
| Return, year to date | +33.5% | -13.8% |
| Return, 1 year | +16.1% | -8.8% |
| P/E (TTM) | 22.4 | -49.2 |
| P/B | 1.4 | -28.6 |
| P/E percentile vs own 5y | – | 5th |
| Dividend yield | 4.42% | – |
| Revenue growth (YoY, latest qtr) | – | +69.6% |
| Net profit growth (YoY) | – | -425.2% |
| Gross margin | – | 93.2% |
| Operating margin | – | 12.0% |
| Net margin | – | -9.2% |
| Return on equity | – | – |
| Analyst target vs. price | – | +52.6% |
| Analyst buy share | – | 82% |
| RSI (14) | 36 | 53 |
| 30-day volatility | 34.4% | 54.4% |
| Max drawdown, 1 year | -30.9% | -33.8% |
| Trend read | Leaning bearish | Leaning bullish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- PTCT is the largest of the group by market value.
- HBRIY has returned the most over the past year.
- PTCT carries the lowest trailing P/E.
- HBRIY has been the calmest stock over the last 30 days.